FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
+13.16%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$143M
AUM Growth
–
Cap. Flow
+$143M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
96.56%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Insmed
INSM
|
$27.4M |
| 2 |
Ascendis Pharma
ASND
|
$21.2M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$20.7M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$17.3M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$13M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 87.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Insmed
INSM
$28.8B
| $27.4M | 19.23% | +879,910 | New | +$27.4M |
|
|
2
Ascendis Pharma
ASND
$11.8B
| $21.2M | 14.86% | +529,343 | New | +$21.2M |
|
|
CBAY
3
DELISTED
Cymabay Therapeutics
CBAY
| $20.7M | 14.54% | +2,254,502 | New | +$20.7M |
|
|
IMMU
4
DELISTED
Immunomedics Inc
IMMU
| $17.3M | 12.16% | +1,073,272 | New | +$17.3M |
|
|
MYOK
5
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $13M | 9.13% | +309,357 | New | +$13M |
|
6
uniQure
QURE
$896M
| $12.4M | 8.72% | +635,234 | New | +$12.4M |
|
|
OPTN
7
DELISTED
OptiNose
OPTN
| $8.51M | 5.96% | +450,000 | New | +$8.51M |
|
8
Aclaris Therapeutics
ACRS
$209M
| $6.21M | 4.36% | +251,936 | New | +$6.21M |
|
|
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.76M | 4.04% | +213,435 | New | +$5.76M |
|
10
Rhythm Pharmaceuticals
RYTM
$6.85B
| $5.09M | 3.57% | +175,000 | New | +$5.09M |
|
|
ALDR
11
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.67M | 1.87% | +232,909 | New | +$2.67M |
|
12
Denali Therapeutics
DNLI
$2.23B
| $1.48M | 1.04% | +94,666 | New | +$1.48M |
|
13
Arbutus Biopharma
ABUS
$711M
| $760K | 0.53% | +150,592 | New | +$760K |
|